To date, the primary identified effectors of variation in CTCF binding at specific loci in cancers include altered DNA methylation at a CTCF motif [20, 21, 30, 47] or mutations affecting the CTCF binding sequence [30]. This evidence concerns the gene CTCF and cancer.